Denali Therapeutics Inc

Suletud

SektorTervishoid

25.7 -0.7

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

25.51

Max

26.35

Põhinäitajad

By Trading Economics

Sissetulek

102K

-128M

Aktsiakasum

-0.69

Töötajad

507

EBITDA

-937K

-126M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+32.6% upside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

7. aug 2026

Turustatistika

By TradingEconomics

Turukapital

854M

3.8B

Eelmine avamishind

26.4

Eelmine sulgemishind

25.7

Uudiste sentiment

By Acuity

40%

60%

104 / 342 Pingereas Healthcare

Denali Therapeutics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

29. juuni 2026, 23:31 UTC

News
Social Media

Comcast shares are higher in after-market trading amid reports of a potential expansion into video games and plans for AI-focused data centers.

29. juuni 2026, 23:26 UTC

Social Media
News

Micron Technology shares are lower after hours amid mixed sentiment and legal challenges over alleged memory chip production manipulation, despite revenue rising to $41.5 billion.

29. juuni 2026, 23:16 UTC

News

O'Reilly Automotive Inc shares are lower in after-market hours, following a slight decline since Monday's close amid a ranking rise in the S&P 500.

29. juuni 2026, 23:11 UTC

News
Correlated Moves

The GBP/HKD is higher today, reaching the upper end of its daily range amid market volatility from renewed U.S.-Iran hostilities ahead of talks in Doha.

29. juuni 2026, 23:06 UTC

News
ETF Constituents

Investor caution persists amid U.S.-Iran tensions, with the Vanguard Growth ETF showing little change in after-market trading. Microsoft leads contributors with a 0.85% return.

29. juuni 2026, 23:06 UTC

News

Regeneron Pharmaceuticals will join the FDA's PreCheck Pilot Program to enhance domestic drug manufacturing. Shares are trading lower in after-market hours.

29. juuni 2026, 23:06 UTC

News

U.S. West Texas Intermediate futures rose to $70.51 per barrel after a U.S.-Iran agreement eased tensions, supporting United States Oil Fund LP in after-market trading.

29. juuni 2026, 23:06 UTC

News

Piper Sandler initiated coverage of PayPal with a Neutral rating and a price target of $42.00. Shares were roughly flat in after-market hours.

29. juuni 2026, 23:02 UTC

News
ETF Constituents
Macro News
Correlated Moves

The Dow Jones Industrial Average closed above 52,000, driven by a rebound in technology stocks. The Vanguard Information Technology ETF showed little change in after-market hours.

29. juuni 2026, 20:07 UTC

News

The USD/THB is lower as optimism grows over U.S.-Iran talks after military exchanges. The asset remains above its 20-day moving average.

29. juuni 2026, 20:07 UTC

News
Correlated Moves

Ethereum is trading higher, supported by easing Middle East tensions and Bitmine's acquisition of 27,084 ETH, raising its total holdings to 5.7 million ETH.

29. juuni 2026, 20:07 UTC

Correlated Moves
Social Media
News
ETF Constituents

Positive sentiment for the SPDR Dow Jones Industrial Average ETF Trust follows a halt in U.S.-Iran military actions, easing geopolitical tensions and supporting stock futures.

29. juuni 2026, 20:07 UTC

Social Media
News

Intel shares are higher as Cantor Fitzgerald raises its price target to $150, indicating a recovery from early session lows.

29. juuni 2026, 20:07 UTC

News

Positive economic indicators and easing U.S.-Iran tensions boost the Nikkei 225 Index higher during after-market hours, with retail sales rising 5.3% year-on-year.

29. juuni 2026, 20:07 UTC

News

USD/ZAR is trading lower as optimism over U.S.-Iran talks eases energy supply concerns. This marks the third consecutive session of declines.

29. juuni 2026, 20:07 UTC

News
Correlated Moves

USD/PLN is lower today, influenced by a decline in the US Dollar Index and improved sentiment from U.S.-Iran relations.

29. juuni 2026, 20:07 UTC

News
Correlated Moves

Gold prices are lower today amid renewed U.S.-Iran tensions and potential Federal Reserve interest rate hikes. Crude oil's rise may diminish gold's safe-haven appeal.

29. juuni 2026, 20:07 UTC

Social Media
Correlated Moves
News

Trading lower amid a declining US Dollar Index; JPMorgan's blockchain impact.

29. juuni 2026, 20:07 UTC

News
Correlated Moves

USD/DKK is trading lower as the US Dollar Index declines. Renewed optimism over U.S.-Iran relations is also influencing market sentiment.

29. juuni 2026, 20:07 UTC

Correlated Moves
News

USD/CZK declines amid a falling US Dollar Index, reflecting volatility in today's session. The pair remains above its 20-day moving average.

29. juuni 2026, 20:06 UTC

News
Correlated Moves

Microchip Technology Inc is rising amid positive momentum in the semiconductor sector, supported by strength in the broader market and a favorable analyst consensus.

29. juuni 2026, 20:06 UTC

Correlated Moves
News

Gold prices are lower today amid renewed U.S.-Iran tensions and concerns over potential Federal Reserve interest rate hikes. Crude oil prices have surged as well.

29. juuni 2026, 20:06 UTC

Correlated Moves
News

USD/NOK is trading lower amid optimism over U.S.-Iran relations, despite remaining above its 20-day moving average. The US Dollar Index has also declined.

29. juuni 2026, 20:04 UTC

ETF Constituents
Correlated Moves
Social Media
News

SPDR S&P 500 ETF Trust advances as U.S. and Iran agree to halt military strikes, boosting market sentiment ahead of a diplomatic summit in Doha.

29. juuni 2026, 20:04 UTC

ETF Constituents
Social Media
News
Correlated Moves

Invesco QQQ Trust rises as U.S.-Iran tensions ease, boosting market sentiment. Strong performance from Amazon and Tesla supports the ETF's advance since Friday.

29. juuni 2026, 20:03 UTC

Social Media
News

Tesla Inc. shares are higher today amid positive delivery forecasts and the closure of an NHTSA investigation into power steering issues.

29. juuni 2026, 20:03 UTC

News
Correlated Moves

Alphabet Inc shares are higher today, supported by increased call volume and a favorable Supreme Court ruling easing regulatory concerns for tech companies.

29. juuni 2026, 20:03 UTC

News
Correlated Moves
Social Media
ETF Constituents

The Communication Services Select Sector SPDR Fund is gaining today, driven by strong performances from GOOGL and META amid a broader tech rally.

29. juuni 2026, 20:03 UTC

Social Media
News

GameStop is pursuing a $56 billion bid for eBay, despite rejection. eBay shares are trading higher amid acquisition discussions and technical platform issues.

29. juuni 2026, 20:03 UTC

Correlated Moves
Social Media
News

Amazon.com Inc. is advancing, supported by a market rally and a new partnership with Park Ha Biological to enhance personal care product offerings.

Võrdlus sarnastega

Hinnamuutus

Denali Therapeutics Inc Prognoos

Hinnasiht

By TipRanks

32.6% tõus

12 kuu keskmine prognoos

Keskmine 34.33 USD  32.6%

Kõrge 42 USD

Madal 23 USD

Põhineb 12 Wall Streeti analüütiku instrumendi Denali Therapeutics Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

12 ratings

12

Osta

0

Hoia

0

Müü

Sentiment

By Acuity

104 / 342 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Denali Therapeutics Inc

Denali Therapeutics Inc., a biopharmaceutical company, develops a portfolio of product candidates engineered to cross the blood-brain barrier for neurodegenerative diseases and lysosomal storage diseases in the United States. The company's transport vehicle (TV)-enabled programs include DNL310 ETV, an IDS enzyme replacement therapy program for MPS II; TAK-594/DNL593 which is in Phase 1/II for frontotemporal dementia-granulin; DNL126 program for MPS IIIA; and DNL622 for MPS I, as well as other preclinical programs that target amyloid beta and HER2. Its brain-penetrant small molecule programs comprise BIIB122/DNL151 LRRK2 inhibitor program for Parkinson's disease; SAR443820/DNL788 RIPK1 inhibitor program for CNS disease; DNL343 eIF2B Activator program for amyotrophic lateral sclerosis; and SAR443122/DNL758 RIPK1 inhibitor program for peripheral inflammatory diseases. It also provides early stage program include TAK-594/DNL593 program for FTD-GRN; DNL126 program for MPS IIIA, a Sanfilippo Syndrome A; DNL622 for MPS I which is Hurler syndrome; Antibody Transport Vehicle Amyloid beta program; Oligonucleotide Transport Vehicle platform, a novel class of biotherapeutics to address the root cause of diseases through modulation of gene expression; and other TV-enabled discovery programs. The company has collaboration agreements with Biogen MA Inc. and Biogen International GmbH; Genzyme Corporation; Takeda Pharmaceutical Company Limited; F-star Gamma Limited, F-star Biotechnologische Forschungs-und Entwicklungsges m.b.H, and F-star Biotechnology Limited; and Genentech, Inc. The company was formerly known as SPR Pharma Inc. and changed its name to Denali Therapeutics Inc. in March 2015. Denali Therapeutics Inc. was incorporated in 2013 and is headquartered in South San Francisco, California.
help-icon Live chat